StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
SORN

Soren Acquisition Corp.

SORNU Nasdaq Blank Checks EDGAR ↗
$10.20
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$74.8M
Revenue (TTM) ⓘ
—
Net income (TTM) ⓘ
—
EPS (TTM) ⓘ
—
P/E ratio ⓘ
—
Dividend yield ⓘ
—
Free cash flow ⓘ
—
Cash ⓘ
$1.80M
Total assets ⓘ
$259M
Gross margin ⓘ
—
52-week range ⓘ
$9.92 – $10.44

AI briefing

from the latest 10-K, 10-Q and 8-K events

Soren Acquisition Corp. is a Cayman Islands blank check company formed in September 2025 that completed a $253 million IPO and is searching for a healthcare-focused business combination.

What they do

Soren Acquisition Corp. is a special purpose acquisition company that has conducted no operations and generated no revenue. Activity to date has been limited to organization, the January 2026 IPO, and identifying a Business Combination target. It intends to focus on healthcare but may pursue a target in any industry or geography.

Revenue drivers

  • Business Combination — The company has no operating revenue and expects none until it consummates an initial Business Combination. Its only income is non-operating interest earned on Trust Account cash and marketable securities.
  • Trust Account interest income — For the three months ended June 30, 2026, interest income on Trust Account cash and marketable securities was $2,259,650, which drove net income of $2,034,431.

Recent performance

For the three months ended June 30, 2026, the company reported net income of $2,034,431, consisting of $2,259,650 of Trust Account interest income partly offset by operating costs. As of June 30, 2026, total assets were $259.3 million, total liabilities were $302,615, and shareholders' equity was $1.7 million. Cash and equivalents outside the Trust Account were $1.8 million. The company has generated no operating revenues since inception on September 2, 2025.

Strategy

Management must complete an initial Business Combination by January 8, 2028, 24 months from the IPO closing, unless the period is extended by charter amendment. It intends to target established businesses of scale, potentially in healthcare, that could benefit from financial, operational, strategic or managerial enhancement. The team cites experience closing four prior SPAC business combinations. If no combination closes, the company will terminate and distribute Trust Account amounts. Nasdaq rules require completion within 36 months, and the company may seek to sell Sponsor interests to another sponsor entity.

Risks

  • No combination by deadline — If no Business Combination is completed by January 8, 2028, the company will terminate and distribute Trust Account amounts unless the Board determines otherwise.
  • Extension and redemption risk — Extending the Combination Period requires Public Shareholder approval and redemption rights, which would reduce Trust Account funds and capitalization and could affect Nasdaq listing.
  • No target selected — The company has not selected any Business Combination target, and its efforts have been limited to organization, the IPO and target search.
  • 2024 SPAC rules — The SEC's 2024 SPAC Rules add disclosure, projection and co-registrant requirements that may materially affect the ability to negotiate and complete a Business Combination and increase costs and time.

Outlook

Management states it expects to continue incurring significant costs pursuing an acquisition and cannot assure shareholders the plan will succeed. It will not generate operating revenue until a Business Combination closes. The company must complete a deal by January 8, 2028, or face termination and Trust Account distribution. It may seek a charter amendment to extend the period or explore a Sponsor interest sale to another sponsor entity.